Skip to main content
news

[KDRA X BXPLANT] Free Strategic Consulting Now Available

By 2026-02-11February 20th, 2026No Comments

BXPLANT is pleased to announce its role as the official strategic partner for the Korea Drug Research Association in providing specialized consulting services. This initiative is designed to enhance the global competitiveness of the biotechnology and pharmaceutical industry by offering comprehensive Research and Development, Clinical Development, and Regulatory Affairs strategies. As a co-development partner, BXPLANT delivers integrated solutions from initial development to successful commercialization and value-up.

Consulting Objectives

The primary objective of this program is to strengthen the development capabilities of member companies and pharmaceutical organizations. By advancing Research and Development and Regulatory strategies, BXPLANT aims to accelerate successful commercialization outcomes and maximize the market value of innovative healthcare assets.

Strategic Service Domains

The consulting service encompasses five core areas of expertise:

  1. Research and Development Strategy

    • Strategic planning for product pipelines and technology validation.

  2. Scientific Evidence Establishment

    • Development of robust data packages and technical merit validation.

  3. Clinical Development and Regulatory Affairs

    • Optimization of clinical pathways and regulatory submission strategies for domestic and international markets.

  4. Clinical Operations and Risk Management

    • Integrated management of clinical trial execution and mitigation of development risks.

  5. Commercialization and Value-up

    • Strategic positioning for market entry, licensing, and investment readiness.

 

Program Details
  • Methodology: 60-minute intensive session per consultation (available via Video Conference or In-Person meeting).

  • Service Fee: Complimentary (Fully sponsored by the partnership).

  • Target Audience: Member companies of the Korea Drug Research Association and pharmaceutical/biotechnology enterprises.

  • Selection Process: Applications are processed on a first-come, first-served basis, with priority given to Korea Drug Research Association member companies.

 

Application Process

✅Dates: Ongoing (Year-round acceptance)

✅Apply here:

https://www.kdra.or.kr/website/05web01.php?id=1620

Leave a Reply